Back to Search
Start Over
Astellas Pharma announces Japan MHLW approval of Padcev with Keytruda
- Source :
- The Fly. September 24, 2024
- Publication Year :
- 2024
-
Abstract
- Astellas Pharma (ALPMY) announced that Japan's Ministry of Health, Labour and Welfare, or MHLW, has approved Padcev with Merck's (MRK) Keytruda as a combination therapy for the first-line treatment of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.809729258